Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EHMT2 | Q96KQ7 | 7/20 | 0.43 |
| ▸ | EHMT1 | Q9H9B1 | 5/20 | 0.43 |
| ▸ | BCL6 | P41182 | 2/20 | 0.42 |
| ▸ | PDE5A | O76074 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | PDE4A | P27815 | 1/20 | 0.40 |
| ▸ | BRD4 | O60885 | 2/20 | 0.39 |
| ▸ | CREBBP | Q92793 | 2/20 | 0.39 |
| ▸ | EP300 | Q09472 | 1/20 | 0.39 |
| ▸ | KDM1A | O60341 | 1/20 | 0.38 |
| ▸ | RCOR1 | Q9UKL0 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4838191 | 0.82 | EHMT2 (0.49) | EHMT2EHMT1BCL6PDE5ASMN1; SMN2 | |
| SCHEMBL5032253 | 0.80 | EHMT2 (0.47) | EHMT2EHMT1BCL6PDE5ASMN1; SMN2 | |
| SCHEMBL4829075 | 0.77 | BCL6 (0.54) | EHMT2EHMT1BCL6SMN1; SMN2LMNA | |
| SCHEMBL6919068 | 0.76 | BCL6 (0.41) | EHMT2EHMT1BCL6SMN1; SMN2PDE4A | |
| SCHEMBL6016904 | 0.75 | BCL6 (0.48) | EHMT2BCL6BRD4LMNAMAPT | |
| SCHEMBL4839209 | 0.75 | EHMT2 (0.50) | EHMT2EHMT1BCL6SMN1; SMN2KDM1A | |
| SCHEMBL4838816 | 0.74 | BCL6 (0.65) | EHMT2EHMT1BCL6SMN1; SMN2LMNA | |
| SCHEMBL5032475 | 0.73 | EHMT2 (0.49) | EHMT2EHMT1BCL6SMN1; SMN2KDM4E | |
| Malonic Acid SCHEMBL4832223 | 0.73 | BCL6 (0.49) | EHMT2EHMT1BCL6SMN1; SMN2BRD4 | |
| SCHEMBL5038228 | 0.73 | BCL6 (0.56) | EHMT2EHMT1BCL6SMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070099874-A1 | Methods and compositions of novel triazine compounds | REDDY US THERAPEUTICS, INC. (US) | 2007-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070099874-A1 | Methods and compositions of novel triazine compounds | AREG, TGFB1, PTGIS | EHMT2 2905/4885EHMT1 2811/4885BCL6 2097/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.